文献速递消化道肿瘤与早癌消化内镜

腺瘤检出率对进展期腺瘤检出及内镜不良事件的影响:超20万例筛查结肠镜研究

Impact of adenoma detection rate on detection of advanced adenomas and endoscopic adverse events in a study of over 200,000 screening colonoscopies.
PubMed 文献 · Gastrointest Endosc · 2019-09-06

该研究分析奥地利质量保证项目中2007至2010年262名内镜医师完成的218,193例筛查结肠镜,按腺瘤检出率(ADR)五分位分组,评估ADR与进展期腺瘤检出率(AADR)及内镜不良事件的关系。

要点

  • ADR提升时非进展期腺瘤与进展期腺瘤检出同步增加,未出现分离。

核心结论

  • 提高ADR与进展期腺瘤检出改善相关,可能有助于预防更多结直肠癌。
  • 较高ADR也伴随较高的内镜不良事件率,但不良事件率总体较低。

研究设计与样本

  • 分析奥地利质量保证项目中2007至2010年262名内镜医师完成的218,193例筛查结肠镜。
  • 按内镜医师ADR五分位分组,计算各组平均进展期腺瘤检出率(AADR)、非进展期腺瘤检出率(NAADR)及不良事件率。
  • 采用Spearman秩相关计算ADR与AADR及不良事件率的相关性,并比较ADR<25%与>25%的内镜医师。

主要发现

  • 患者中女性占51%。
  • 平均ADR为23.03%(95%CI 21.93-24.13),平均AADR为7.72%(95%CI 7.19-8.25),平均NAADR为15.31%(95%CI 14.36-16.27)。
  • 最高ADR组(ADR 31.36%-52.27%)平均AADR进一步升至10.75%(95%CI 9.31-12.19)。
  • NAADR随ADR改善持续增加,但始终与AADR同步改善而未分离。

关键数值与推荐

  • 指南推荐目标ADR>25%,基于既往研究显示较高ADR医师的患者结肠镜后间期癌风险较低。

临床怎么用

  • 筛查结肠镜质量改进应继续以ADR为关键指标,因其与进展期腺瘤检出改善相关。
  • 在提升ADR的同时需关注内镜不良事件,尽管本研究中不良事件率较低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Adenoma detection rate (ADR) is the best established quality parameter for screening colonoscopy. Guidelines recommend a target ADR >25% because previous studies have shown that patients of endoscopists with higher ADRs have a lower risk of postcolonoscopy interval cancers. However, studies have shown that improvement in ADR mainly results in increased detection of clinically irrelevant nonadvanced adenomas (NAAs). The impact of ADR on the detection of advanced adenomas (AAs) as well as adverse event rates has yet to be determined. METHODS: A total of 218,193 screening colonoscopies performed between 2007 and 2010 by 262 endoscopists within the Austrian quality assurance program were analyzed. We divided endoscopists into quintiles based on ADRs and calculated mean advanced ADRs (AADRs), NAA detection rates (NAADRs), and adverse event rates for each quintile. Spearman rank-order was used to calculate overall correlations between ADRs and AADRs as well as adverse event rates. Endoscopists with an ADR <25% were compared with those with an ADR >25%. RESULTS: Fifty-one percent of patients were women. Mean ADR was 23.03% (95% confidence interval [CI], 21.93-24.13), AADRs 7.72% (95% CI, 7.19-8.25), and NAADRs 15.31% (95% CI, 14.36-16.27). Overall, there was a significant correlation between ADR and AADR (rho = .51; P < .001). When ADR was divided into quintiles, mean AADR increased with increasing ADR. Even in the highest ADR group (ADR, 31.36%-52.27%) there was a further increase in AADR with a mean of 10.75% (95% CI, 9.31-12.19). Importantly, NAADRs increased continuously with improvement in ADRs but never dissociated from a simultaneous improvement in AADRs. However, there was also a significant correlation of ADRs and endoscopic adverse events (rho = .26, P < .001), even if the perforation rate of .028% (95% CI, .004-.052) in the highest ADR group still remained within the accepted limits based on guidelines. CONCLUSIONS: Increasing ADR is associated with improved detection of AAs and therefore is likely to prevent more cases of colorectal cancer. However, higher ADR was also associated with a higher rate of adverse events, although the adverse event rate was low.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Penz D, Ferlitsch A, Waldmann E, et al. Impact of adenoma detection rate on detection of advanced adenomas and endoscopic adverse events in a study of over 200,000 screening colonoscopies. Gastrointest Endosc. 2019. PMID: 31499041. doi:10.1016/j.gie.2019.08.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。